InfuSystems Holdings, Inc. (INFU): Price and Financial Metrics


InfuSystems Holdings, Inc. (INFU): $7.04

0.21 (+3.07%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

INFU POWR Grades

  • Stability is the dimension where INFU ranks best; there it ranks ahead of 93.37% of US stocks.
  • INFU's strongest trending metric is Stability; it's been moving up over the last 177 days.
  • INFU's current lowest rank is in the Momentum metric (where it is better than 43.87% of US stocks).

INFU Stock Summary

  • INFU's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 273.36 -- higher than 91.55% of US-listed equities with positive expected earnings growth.
  • Of note is the ratio of INFUSYSTEM HOLDINGS INC's sales and general administrative expense to its total operating expenses; 85.37% of US stocks have a lower such ratio.
  • In terms of twelve month growth in earnings before interest and taxes, INFUSYSTEM HOLDINGS INC is reporting a growth rate of -86.17%; that's higher than just 17.44% of US stocks.
  • Stocks that are quantitatively similar to INFU, based on their financial statements, market capitalization, and price volatility, are NEGG, KRUS, LWAY, CVET, and STKL.
  • Visit INFU's SEC page to see the company's official filings. To visit the company's web site, go to www.infusystem.com.

INFU Valuation Summary

  • In comparison to the median Healthcare stock, INFU's price/earnings ratio is 1298.47% lower, now standing at -234.9.
  • Over the past 179 months, INFU's EV/EBIT ratio has gone up 81.3.

Below are key valuation metrics over time for INFU.

Stock Date P/S P/B P/E EV/EBIT
INFU 2022-09-23 1.3 3.0 -234.9 222.5
INFU 2022-09-22 1.3 3.1 -242.5 228.2
INFU 2022-09-21 1.4 3.1 -246.0 230.8
INFU 2022-09-20 1.4 3.3 -257.8 239.6
INFU 2022-09-19 1.5 3.3 -261.7 242.5
INFU 2022-09-16 1.4 3.2 -251.9 235.2

INFU Growth Metrics

    Its 2 year net cashflow from operations growth rate is now at 49.99%.
  • The 3 year price growth rate now stands at 97.45%.
  • Its year over year net cashflow from operations growth rate is now at -11.76%.
Over the past 70 months, INFU's revenue has gone up $34,505,000.

The table below shows INFU's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 106.89 18.997 -0.593
2022-03-31 104.682 19.743 0.391
2021-12-31 102.382 18.316 1.42
2021-09-30 100.574 22.217 11.703
2021-06-30 99.133 24.832 15.091
2021-03-31 100.298 22.374 18.411

INFU's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • INFU has a Quality Grade of B, ranking ahead of 82.85% of graded US stocks.
  • INFU's asset turnover comes in at 1.09 -- ranking 17th of 186 Medical Equipment stocks.
  • ADMT, BLFS, and ESMC are the stocks whose asset turnover ratios are most correlated with INFU.

The table below shows INFU's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.090 0.603 0.060
2021-03-31 1.140 0.605 0.102
2020-12-31 1.133 0.603 0.097
2020-09-30 1.157 0.601 0.103
2020-06-30 1.121 0.593 0.087
2020-03-31 1.082 0.582 0.049

INFU Stock Price Chart Interactive Chart >

Price chart for INFU

INFU Price/Volume Stats

Current price $7.04 52-week high $19.14
Prev. close $6.83 52-week low $6.52
Day low $6.65 Volume 35,800
Day high $7.11 Avg. volume 112,040
50-day MA $8.07 Dividend yield N/A
200-day MA $10.43 Market Cap 145.69M

InfuSystems Holdings, Inc. (INFU) Company Bio


InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was founded in 2005 and is headquartered in Madison Heights, Michigan.


INFU Latest News Stream


Event/Time News Detail
Loading, please wait...

INFU Latest Social Stream


Loading social stream, please wait...

View Full INFU Social Stream

Latest INFU News From Around the Web

Below are the latest news stories about INFUSYSTEM HOLDINGS INC that investors may wish to consider to help them evaluate INFU as an investment opportunity.

InfuSystem Appoints R. Rimmy Malhotra to the Board of Directors

ROCHESTER HILLS, Mich., September 23, 2022--InfuSystem Appoints R. Rimmy Malhotra to the Board of Directors

Yahoo | September 23, 2022

InfuSystem to Participate in Lake Street’s 6th Annual Best Ideas Growth (BIG6) Conference September 14, 2022

ROCHESTER HILLS, Mich., September 07, 2022--InfuSystem to Participate in Lake Street’s 6th Annual Best Ideas Growth (BIG6) Conference September 14, 2022

Yahoo | September 7, 2022

InfuSystem Reports Second Quarter 2022 Financial Results

ROCHESTER HILLS, Mich., August 04, 2022--InfuSystem Reports Second Quarter 2022 Financial Results

Yahoo | August 4, 2022

InfuSystem to Report Second Quarter 2022 Financial Results on August 4, 2022

ROCHESTER HILLS, Mich., July 29, 2022--InfuSystem to Report Second Quarter 2022 Financial Results on August 4, 2022

Yahoo | July 29, 2022

InfuSystem and Ventis Pharma Announce National Sales and Marketing Agreement for Pain Management

ROCHESTER HILLS, Mich., June 14, 2022--InfuSystem and Ventis Pharma Announce National Sales and Marketing Agreement for Pain Management

Yahoo | June 14, 2022

Read More 'INFU' Stories Here

INFU Price Returns

1-mo -8.69%
3-mo -27.20%
6-mo -28.60%
1-year -45.97%
3-year 32.33%
5-year 243.41%
YTD -58.66%
2021 -9.32%
2020 120.16%
2019 147.97%
2018 49.57%
2017 -9.80%

Continue Researching INFU

Want to see what other sources are saying about InfuSystem Holdings Inc's financials and stock price? Try the links below:

InfuSystem Holdings Inc (INFU) Stock Price | Nasdaq
InfuSystem Holdings Inc (INFU) Stock Quote, History and News - Yahoo Finance
InfuSystem Holdings Inc (INFU) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5891 seconds.